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ABSTRACT
Leptin administration potentiates the satiety response to signals
such as cholecystokinin (CCK), that are released from the gut during
a meal. To investigate the physiological relevance of this observation,
we hypothesized that leptin deficiency, induced by fasting, attenuates
the satiety response to CCK. To test this hypothesis, 48-h-fasted or fed
rats were injected with ip saline or CCK. Fasting blunted the satiety
response to 3.0 mg/kg CCK, such that 30-min food intake was sup-
pressed by 65.1% (relative to saline-treated controls) in fasted rats vs.
85.9% in the fed state (P , 0.05). In a subsequent experiment, rats
were divided into three groups: 1) vehicle/fed; 2) vehicle/fasted; and
3) leptin-replaced/fasted; and each group received 3.0 mg/kg ip CCK.
As expected, the satiety response to CCK was attenuated by fasting
in vehicle-treated rats (30-min food intake: vehicle/fed, 0.3 6 0.1 g;
vehicle/fasted, 1.7 6 0.4 g; P , 0.01), and this effect was prevented
by leptin replacement (0.7 6 0.2 g, P , 0.05 vs. vehicle/fasted; P 5 not
significant vs. vehicle/fed). To investigate whether elevated neuropep-
tide Y (NPY) signaling plays a role in the effect of leptin deficiency to
impair the response to CCK, we measured the response to 3.0 mg/kg
ip CCK after treatment with 7.5 mg intracerebroventricular NPY. We
found that both CCK-induced satiety and its ability to increase c-Fos-
like-immunoreactivity in key brainstem-feeding centers were atten-
uated by NPY pretreatment. We conclude that an attenuated re-
sponse to meal-related satiety signals is triggered by leptin deficiency
and may contribute to increased food intake. (Endocrinology 141:
4442–4448, 2000)
INCREASED FOOD INTAKE is an important componentof the adaptive response, after fasting, that promotes the
recovery of depleted fuel stores. Leptin deficiency is impli-
cated in this response because reduced leptin signaling oc-
curs in fasted animals and is the cause of hyperphagia in
genetically obese ob/ob and db/db mice and fa/fa rats. Increased
food intake that occurs in leptin-deficient conditions is char-
acterized by increased meal size rather than more frequent
meals (1–3), whereas leptin-induced anorexia in normal ro-
dents is characterized by decreased meal size (4, 5) with no
change of meal frequency (4). These findings support the
hypothesis that leptin reduces energy intake primarily by
reducing the size of individual meals, whereas leptin defi-
ciency elicits the opposite effect.
During a meal, neural and humoral signals are generated
in response to nutrient ingestion that induce satiety and meal
termination. Among these stimuli are satiety factors, one of
which is cholecystokinin (CCK). CCK was first isolated in
1964 (6) and has since been extensively studied for its role in
ingestive behavior (for a review, see Ref. 7). CCK reduces
food intake, within minutes after its release from the upper
duodenum and jejunum (8), by binding to CCK-A receptors
on afferent fibers of the vagus nerve. The vagus nerve trans-
mits ingestive information to brainstem areas implicated in
satiety, including the nucleus of the solitary tract (NTS), which,
in turn, projects fibers to the brainstem’s lateral parabrachial
nucleus (L-PBN) and the hypothalamic paraventricular nucleus
(PVN) (9–11). Thus, systemic CCK administration to rats rap-
idly inhibits food intake and activates neurons (as measured by
c-Fos induction) in brain stem and hypothalamic areas.
Coadministration of CCK with leptin potentiates its ability
to reduce food intake (12–15) and to activate neurons in the
NTS (13, 14, 16). These findings support a model in which
leptin’s anorectic effects are mediated, at least in part, by
enhancing the response of brainstem neurons to CCK. We
therefore hypothesized that reduced leptin signaling, in-
duced by fasting, attenuates the response to satiety signals,
which, in turn, increases food intake. To test this hypothesis,
we first measured the effect of fasting on the satiety response
to ip CCK. To explore the specific role of leptin deficiency in
the effect of food deprivation, we performed a second exper-
iment in which fasted animals were infused systemically with
a dose of leptin intended to maintain circulating leptin at non-
fasted levels, and the satiety response to CCK was compared
with that of fasted animals receiving no leptin replacement.
One mechanism by which decreased leptin signaling may
increase food intake is via increased synthesis of hypotha-
lamic peptides that stimulate feeding, such as neuropeptide
Y (NPY). We therefore hypothesized that NPY increases food
intake, at least in part, by attenuating the response of neurons
in the brainstem, to satiety signals such as CCK. This hy-
pothesis was investigated by determining the effect of in-
tracerebroventricular (icv) NPY pretreatment on both CCK-
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induced satiety and on the ability of CCK to induce c-Fos
expression in areas of the brain that regulate food intake.
Materials and Methods
Animals
All studies used male Wistar rats weighing 300–350 g (Simonsen
Laboratories, Inc., Gilroy, CA), housed individually in polycarbonate
cages (Experiments 1, 2, and 3) or wire-mesh hanging cages (Exp 4) in
a temperature-controlled vivarium, on a 12-h light, 2-h dark schedule.
Unless otherwise specified, animals were given free access to pelleted rat
chow (Ralston Purina Co., St. Louis, MO) and water at all times. All
procedures were performed according to institutional guidelines and
were approved by the Animal Care and Use Committee at the Puget
Sound Veterans Affairs Health Care Center and the University of
Washington.
Exp 1: Effect of fasting on CCK-induced satiety
Forty-five rats were weighed and handled daily and habituated to ip
saline vehicle injections 1 week before the beginning of the experiments.
Ad libitum fed protocol. Food hoppers were removed from cages at 1500 h
and weighed. Animals were weight-matched into treatment groups and
injected ip between 1745 h and 1800 h, in randomized order, with
sulfated CCK octapeptide (Peninsula Laboratories, Inc., Belmont, CA),
at doses of 0.5, 0.8, and 3.0 mg/kg, diluted up to 2 ml in 0.9% saline
solution, or saline for control. Each rat was allowed access to chow
immediately after the injection, at a time corresponding to the beginning
of the dark cycle (1815 h). Food consumption was measured 30 min, 90
min, and 4 h after CCK administration.
Fasted protocol. Food hoppers were removed from cages, at 1500 h, 2 days
before the feeding experiment. On the day of the experiment, fasted
animals were weight-matched into treatment groups, injected ip in ran-
domized order with either saline or CCK, and monitored for intake of
chow as described above.
Half of the animals were divided into four groups and received one
of the three doses of CCK or vehicle in the fed condition, followed by
the same treatment in the fasted condition 10 days later. The remaining
animals received the same injection treatments in the fasted condition
first; and 10 days later, they were injected in the fed condition. This
cross-over design was repeated after 10 days recovery, and the results
were analyzed together.
Exp 2: Effect of leptin replacement on the response
to fasting
Intrajugular catheter placement. Rats were habituated with daily handling
for 8 weeks before surgery. After anesthesia, induced by ip injection of
ketamine/xylazine (60 mg/kg ketamine and 8 mg/kg xylazine), a sterile
silicon catheter (ID, 0.020; OD, 0.037 inches) was placed into the right
jugular vein using the method of Steffens (17). Two weeks of surgical
recovery were allowed before performing the experiment, during which
time rats were weighed daily and habituated to the blood sampling
procedure.
Study protocol. Delivery of infusate via minipump was achieved by
attaching a polyethylene Lynch coil (18), filled with a precise volume of
either vehicle or peptide. Twenty-three jugular-catheterized animals
were weight-matched into three groups (average BW 5 406.4 6 7.0 g):
vehicle/fed, vehicle/fasted, and leptin/fasted. After anesthesia, in-
duced by ip injection of ketamine/xylazine, all rats were implanted with
sc minipumps with attached Lynch coils that delivered 0.9% saline for
the first 48 h after minipump placement, so that infusion of test sub-
stances did not commence until after this postsurgical recovery period.
After this initial 48-h period, food was removed for 48 h from the
vehicle/fasted (n 5 8) and leptin/fasted (n 5 7) groups, during which
time the vehicle/fed group (n 5 8) was allowed free access to food.
Minipumps delivered either 5 mm sodium citrate vehicle sc, or 100
mg/kgzday sc of murine leptin (Peprotech, Inc., Rocky Hill, NJ) dissolved
in sodium citrate vehicle at pH 4.0, a rate chosen according to a protocol
used previously (19). A jugular vein blood sample was collected from
each rat, 44 h into the fast, to measure plasma leptin levels.
The infusions of leptin or vehicle were designed to finish just before
the beginning of the dark cycle (1715 h) on the second day of the fast and
were followed by a 0.9% saline infusion delivered by the minipumps for
the remainder of the study. At 1400 h, food was removed from the cages
of the vehicle/fed group. All animals were injected, in randomized
order, with 3 mg/kg ip CCK, between 1645 h and 1655 h, and food was
immediately returned to all cages. Food intake was measured at 30 min,
90 min, 4 h, and 24 h after injection.
To determine the effect of the leptin replacement protocol on food
intake in the absence of CCK, the experiment was repeated after 1 month
recovery, using ip saline instead of CCK, in a subset of these animals (n 5
17, average BW 5 425.3 6 8.1 g). Each animal was maintained in its
previous treatment group.
Exp 3: Effect of icv NPY on CCK-induced satiety and
c-Fos induction
Cannula placement. Rats were habituated with daily handling for 1 week
before surgery. After anesthesia, induced by ip injection of ketamine/
xylazine, a 21-gauge cannula (Plastics One, Roanoke, VA) was placed
stereotaxically into the third ventricle using a previously described
method (20, 21). Cannula placement was verified, 1 week after surgery,
by icv injection of 10 ng angiotensin II (American Peptide Co., Sunny-
vale, CA) diluted in 1 ml cerebrospinal fluid (CSF). Animals not con-
suming at least 5 ml water within 30 min post injection were excluded
as cannulation failures (4% of all rats).
Exp 3.1. To determine the effect of icv NPY pretreatment on CCK-
induced inhibition of food intake, 19 rats were weight-matched to 4
groups, 3 weeks after cannula placement in the third ventricle. The 4
groups studied were: icv CSF/ip saline treatment (n 5 4), icv CSF/ip
CCK (n 5 5), icv NPY/ip saline (n 5 5), and icv NPY/ip CCK (n 5 5).
At 1400–1500 h, each animal received an icv injection of 3.5-ml vol of
either synthetic CSF or 7.5 mg NPY in the same volume of CSF, and food
was removed from the cages. At approximately 1745–1755 h, either ip
saline or 3.0 mg/kg ip CCK was administered in randomized order, and
food was immediately returned to the cages. Food intakes were collected
30 min, 90 min, 4 h, and 24 h after returning food to the cages. After a
10-day recovery period, the same animals were reassigned to groups
such that those that had previously received an ip saline treatment now
received ip CCK and vice versa, while the icv treatment groups remained
as before. In this way, each animal served as its own control for the ip
treatments. The results of the 2 trials were similar, and the data were
therefore analyzed together.
Exp 3.2. To determine the effect of icv NPY pretreatment on CCK-
induced c-Fos staining, a different group of 29 rats was habituated to ip
injections and weight-matched into the following 4 groups after can-
nulation of the third ventricle: icv CSF/ip saline (n 5 8), icv CSF/ip CCK
(n 5 7), icv NPY/ip saline (n 5 7), and icv NPY/ip CCK (n 5 7).
Third-ventricle injections of either 3.5 ml CSF or 7.5 mg NPY, in an equal
volume of CSF, were administered to all rats, followed 1 h later by an
ip injection of either ip saline or 3 mg/kg ip CCK. Immediately after-
wards, each animal was returned to its home cage with food hoppers and
water bottles removed. After 110 min, rats were anesthetized with ket-
amine/xylazine and transcardially perfused with PBS of neutral pH,
followed by a 4% paraformaldehyde solution. Brains were removed
immediately and postfixed in paraformaldehyde, for 1 week, before
assay for c-Fos-like-immunoreactivity (cFLI).
Assays and data analyses
Leptin assay. Plasma leptin levels were determined by RIA using an
antibody with 100% cross-reactivity for both rat and murine leptin
(Linco Research, Inc., St. Louis, MO) (22).
cFLI. Each postfixed brain was rinsed 2–3 times in PBS and sectioned,
at 50 mm, on an oscillating tissue slicer in a PBS bath. Coronal sections
were taken from the forebrain (PVN) and from the hindbrain (L-PBN,
NTS, and area postrema, AP) and were processed for cFLI as described
in detail elsewhere (23). Sections were mounted on slides, and the
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number of cFLI-positive cell nuclei was quantified in selected brain areas
by an investigator blinded to the treatment groups. Quantification was
performed using the MCID computer grain counting system (Imaging
Research, Inc., St. Catherine’s, Ontario, Canada).
Statistical analyses. All statistical analyses were carried out using Prism
2.01 (GraphPad Software, Inc., San Diego, CA) statistical software. Data
are presented as group mean values (6sem). For experiments with
greater than two study groups, comparisons were performed with one-
way ANOVA and Neuman-Keuls post hoc test. A paired, two-tailed
Student’s t test was used for two-group comparisons in Exp 1. A P
value 5 0.05 between group mean values was considered statistically
significant.
Results
Exp 1: Effect of fasting on CCK-induced satiety
To determine the effect of fasting on CCK-induced satiety,
30-min food intake was measured after ip injection of saline
or one of three doses of CCK in rats that were either fasted
48 h or fed ad libitum. The average food intake for saline-
treated rats fed ad libitum was 3.2 6 0.3 g; and for 48-h-fasted
rats, 4.3 6 0.2 g in the first 30 min after lights out (P , 0.05).
CCK reduced food intake over this time period in a dose-
dependent manner in both the fed and fasted groups, but the
effect of CCK (relative to saline-treated controls) was signif-
icantly greater in fed, compared with fasted, rats at the 3.0-
mg/kg dose (0.5 6 0.1 g fed, 1.5 6 0.3 g fasted, P , 0.001 for
each, compared with ip saline). The percent suppression of
30-min food intake in fed and fasted animals at this dose was
85.9% and 65.1%, respectively, compared with saline controls
(Fig. 1, P , 0.05 for percent saline control-fed vs. percent
saline control-fasted).
Exp 2: Effect of leptin replacement on the response
to fasting
To investigate whether leptin deficiency, induced by fast-
ing, contributes to the attenuated satiety response to CCK,
the effect of leptin infusion at a dose intended to replace basal
levels in fasted rats was determined. Leptin levels were re-
duced by 82% in vehicle/fasted vs. vehicle/fed rats (0.3 6 0.1
vs. 1.6 6 0.2 ng/mL; P , 0.001) and this effect was prevented
by sc leptin infusion (1.7 6 0.2 ng/mL; P , 0.001 vs. vehicle/
fasted, Fig. 2). Food consumed after 3.0 mg/kg ip CCK was
greater in vehicle/fasted, compared with vehicle/fed, rats
(30-min food intake: vehicle/fasted, 1.7 6 0.4 g, P , 0.01;
vehicle/fed, 0.3 6 0.1 g), in agreement with Exp 1, and this
increase was markedly attenuated in leptin/fasted rats (0.7 6
0.2 g, P , 0.05 vs. vehicle/fasted; P 5 not significant vs.
vehicle/fed, Fig. 2). This pattern persisted over the 24-h
refeeding period (data not shown).
To determine whether leptin replacement affects 30-min
food independently of CCK, the experiment was repeated in
a subset of the same animals, substituting ip injections of
saline for that of CCK. As in the previous trial, leptin levels
were markedly reduced in vehicle/fasted rats (by 71% in
vehicle/fasted vs. vehicle/fed rats; 0.7 6 0.1 vs. 2.6 6 0.3
ng/mL; P , 0.01), and this effect was again prevented by sc
leptin infusion (2.2 6 0.5 ng/mL, P , 0.01 vs. vehicle/fasted)
(Fig. 3). In the absence of CCK, 30-min food intake in the two
groups of fasted animals was greater than that of fed rats, and
leptin replacement did not significantly affect this response
(30-min food intake: 4.7 6 0.3 and 4.2 6 0.6 g in vehicle/
fasted and leptin/fasted groups vs. 1.9 6 0.4 g in vehicle/fed
animals, P , 0.01 for both fasted vs. fed groups) (Fig. 3). This
pattern persisted over the 24-h refeeding period (data not
shown).
FIG. 1. Food intake, measured for 30 min after ip administration of
either saline vehicle or 0.5, 0.8, or 3.0 mg/kg CCK, in rats fed ad
libitum or fasted for 48 h. Data are expressed as percent of the intake
in vehicle-treated controls. *, P , 0.05 for fasted vs. fed animals at the
3.0-mg/kg dose.
FIG. 2. Top, Thirty-minute food intake, measured after ip adminis-
tration of CCK (3.0 mg/kg ip) in rats fed ad libitum that received sc
vehicle (VEH) (open bar; n 5 11) or in rats that were fasted for 48 h
and received either sc vehicle (striped bar; n 5 11) or leptin (LEP) at
a dose intended to replace basal levels (filled bar; n 5 10). Bottom,
Plasma leptin levels, measured 4 h before CCK administration, in the
same groups. *, P , 0.05; **, P , 0.01; ***, P , 0.001.
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Exp 3: Effect of icv NPY on CCK-induced satiety and
c-Fos induction
Exp 3.1. To determine whether NPY pretreatment attenuates
the feeding response to CCK, rats received either 7.5 mg icv
NPY or icv CSF, followed 2 h later by 3.0 mg/kg ip CCK or
ip saline. Average food intake of icv CSF/ip saline-treated
rats was 2.6 6 0.5 g in the first 30 min after lights out (Fig.
4). Similar to previous experiments, CCK reduced 30-min
food intake to 0.2 6 0.04 g (P , 0.01 vs. vehicle) in rats
receiving icv CSF vehicle. By comparison, food intake of rats
receiving 7.5 mg icv NPY and ip saline was increased to 5.2 6
0.5 g (P , 0.001 vs. vehicle), whereas food intake of icv
NPY/ip CCK-treated rats was similar to that of icv CSF/ip
saline-treated rats (1.9 6 0.4 g). The relative reduction of
30-min food intake induced by CCK in the icv CSF group was
therefore greater than in the group receiving icv NPY (92 vs.
63%; P , 0.001).
Exp 3.2. In a separate group of rats, the effect of 7.5 mg icv
NPY pretreatment on neuronal c-Fos staining, induced by 3.0
mg/kg ip CCK, was determined using a protocol similar to
that of Exp 3.1, except that food and water were not available
to the animals at any time after the injections. Representative
sections showing cFLI in the NTS and AP are shown in Fig.
5A. The mean number of cFLI-positive nuclei in the NTS
increased by 960% after treatment with ip CCK, compared
with ip saline, among icv CSF-treated animals (101.8 6 10.2
vs. 9.6 6 2.5 cFLI-positive nuclei, P , 0.001), and this re-
sponse was lowered by 35% in rats pretreated with icv NPY
(65.9 6 11.9 cFLI-positive nuclei, P , 0.01 vs. icv CSF/ip
CCK-treated animals) (Fig. 5B). cFLI-positive nuclei were
also markedly increased in the AP after ip CCK, compared
with ip saline, in the icv CSF group (153.0 6 6.3 vs. 9.6 6 2.7
cFLI-positive nuclei, P , 0.001), and this effect was attenu-
ated by 28% in animals pretreated with icv NPY (110.2 6 21.3
cFLI-positive nuclei, P , 0.05). In contrast, NPY pretreatment
did not attenuate CCK-induced c-Fos expression in the PVN
or the L-PBN, brain areas in which icv NPY and ip CCK
elicited similar cFLI patterns (Fig. 5, A and B). NPY given in
the absence of CCK also increased for staining in the NTS,
L-PBN, and PVN, in relation to icv vehicle.
Discussion
The recent finding that leptin administration potentiates
the satiety response to CCK (12–15) supports a model in
which signals involved in long-term energy homeostasis
(such as leptin) influence food intake via an interaction with
short-term signals (such as CCK) that control the size of
individual meals. The observation that ob/ob mice with ge-
netic obesity caused by mutation of the leptin gene are rel-
atively insensitive to CCK-induced satiety provides addi-
tional support for this concept (24, 25). In the current
experiments, we wished to determine whether leptin signal-
ing is required for an intact response to satiety signals in
genetically normal animals. We hypothesized that previous
observations suggesting that fasting blunts responsiveness to
FIG. 3. Top, Thirty-minute food intake, measured after ip adminis-
tration of saline, in rats fed ad libitum that were treated with sc
vehicle (open bar; n 5 5), or in rats that were fasted for 48 h and
received either sc vehicle (striped bar; n 5 7) or leptin at a dose
intended to replace basal values (filled bar; n 5 5). Bottom, Plasma
leptin levels, measured 4 h before CCK administration, in the same
groups. **, P , 0.01; ***, P , 0.001.
FIG. 4. Thirty-minute food intake, measured after administration of
either icv vehicle/ip vehicle (open bar; n 5 9), icv vehicle/ip CCK (gray
bar; n 5 9), icv NPY/ip vehicle (striped bar; n 5 10), or icv NPY/ip CCK
(filled bar; n 5 10) in rats. ip CCK and icv NPY doses were 3.0 mg/kg
and 7.5 mg, respectively. SAL, Saline; **, P , 0.01; ***, P , 0.001.
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exogenous CCK (26–31) may be explained by reduced leptin
signaling.
To test this hypothesis, we first confirmed the ability of a
48-h fast to attenuate CCK-induced satiety in rats. We then
demonstrated, in a second experiment, that this effect of
fasting was prevented by infusion of leptin at a dose that
achieved plasma levels comparable with those of ad libitum-
fed animals. Thus, leptin deficiency seems to play a key role
in the effect of fasting to reduce the response to exogenous
CCK. In addition, we showed that the suppression of food
FIG. 5. A, Representative photomicrographs of cFLI in coronal sections of rat brain stem at the level of the NTS and AP in animals from each
of the four groups in Exp 3.2. CCK-induced expression of cFLI in both the NTS and AP is attenuated in animals receiving icv NPY pretreatment;
B, numbers of cFLI-containing neurons in rat NTS, AP, L-PBN, and PVN measured after administration of either icv vehicle/ip vehicle (open
bar), icv vehicle/ip CCK (gray bar), icv NPY/ip vehicle (striped bar), or icv NPY/ip CCK (filled bar) (n 5 5–8/group). ip CCK and icv NPY doses
were 3.0 mg/kg and 7.5 mg, respectively. *, P , 0.01 vs. icv vehicle/ip vehicle; †, P , 0.05 vs. icv vehicle/ip CCK.
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intake elicited by CCK was attenuated by pretreatment with
icv NPY, an intervention that also reduced the number of
c-Fos-positive nuclei induced by CCK in hindbrain areas
strongly implicated in CCK-induced satiety. Taken together,
these findings support the hypothesis that the decrease in
leptin signaling, induced by fasting, blunts the satiety re-
sponse to CCK and that fasting-induced increases of NPY
may contribute to this response.
Our results are consistent with several previous studies
showing that CCK-induced food intake suppression is re-
duced when animals are fasted (26–31). Leptin replacement
reversed the effect of fasting to attenuate the response to
CCK, amounting to a recovery of 59% of the response mea-
sured in rats fed ad libitum (P , 0.05 vs. fasted animals
receiving vehicle). The fact that CCK suppression of food
intake was incompletely restored by leptin replacement in
fasted animals raises the possibility that another circulating
factor, such as insulin, may also enhance CCK-induced sa-
tiety. This possibility is supported by the observations that,
like leptin, insulin levels are markedly decreased by fasting,
and icv insulin infusion synergistically reduces food intake
when coadministered with systemic CCK (32).
The interaction between leptin infusion and CCK was tran-
sient, however. Food intake increased in the leptin-replaced
group such that, by 4 h, the fasted groups were no longer
significantly different from one another, and the recovery of
lost weight after 24 h of refeeding did not differ among
leptin- and vehicle-treated groups (data not shown). The
latter finding is discordant with the results of two previous
studies in which coadministration of leptin with CCK elicited
a synergistic suppression of food intake and body weight in
lean rats that lasted for 2 days (15, 33), but it is in agreement
with a more recent study that did not detect this interaction
(34). Our study differs from all three of these previous stud-
ies, however, in that we sought to achieve physiological
leptin replacement during a fast rather than to administer
leptin at supraphysiological doses in ad libitum-fed animals.
Conversely, when saline was given instead of ip CCK, food
intake in fasted, saline-treated animals was not significantly
attenuated by leptin replacement at any time point. Thus, the
restoration of the CCK response seen in fasted, leptin-
replaced animals in the first trial was not attributable to an
independent effect of leptin on food intake. Moreover, it
seems that leptin replacement in fasted animals does not
reduce fasting-induced hyperphagia. Preventing the decline
in plasma leptin levels may therefore be insufficient, in and
of itself, to attenuate hyperphagia in response to fasting, and
additional studies are warranted to address this possibility.
One potential explanation for this outcome is that fasting
lowers basal plasma and duodenal levels of satiety factors
such as CCK (35–38), gastrin (35), secretin (36), and glucagon-
like-peptide-1 (36). By giving CCK, we may have overridden
a fasting-induced reduction of satiety signals, thereby per-
mitting the interaction between leptin and CCK to be de-
tected. In fasted rats that did not receive CCK, however,
levels of satiety signals during refeeding may have been too
low to interact effectively with leptin.
Several possible mechanisms may be considered to explain
an effect of leptin deficiency to inhibit the satiety effect of
CCK. The ability of ip CCK to activate NTS neurons is well-
documented and is believed to involve stimulation of vagal
afferent fibers from the gut that synapse in this brain area (7,
9). Because leptin receptors are present in caudal brainstem
areas, such as the NTS (39), the possibility of a local inter-
action of leptin with CCK at this site may be considered. In
this scenario, leptin is proposed to act locally in the NTS to
potentiate the activation of hindbrain neurons by CCK or
other satiety signals. Alternatively, leptin could act indirectly
to influence the response of hindbrain neurons to CCK or
other satiety signals. For example, many leptin-sensitive neu-
rons of the ARC project, either directly or indirectly, to the
hindbrain, where they may influence the response to CCK
and other vagally mediated stimuli (40).
NPY neurons of the ARC provide one example of a path-
way downstream of leptin signaling with the potential to
mediate some of the effects of leptin deficiency on the re-
sponse to CCK. Hypothalamic NPY synthesis and release
increase during fasting (20, 41, 42), and this response is sup-
pressed by leptin (43). Leptin receptors are present on ARC
NPY neurons, especially those that are upregulated with
fasting (44), and elevated ARC NPY biosynthesis is impli-
cated in the hyperphagia of leptin-deficient, ob/ob mice (45,
46). ARC NPY neurons project to the PVN and other hypo-
thalamic areas with well-defined projections to the NTS (40).
In the current studies, we found that, when rats were
pretreated with third ventricular NPY or CSF vehicle 1–2 h
before administering ip CCK or saline vehicle, the feeding
effects of NPY and CCK offset one another. Thus, NPY/
CCK-treated animals ate the same amount of food as vehi-
cle/vehicle-treated animals in the first 30 min after ip injec-
tion, in agreement with the hypothesis that NPY blocked
CCK-induced satiety. The results of our study, however,
could also be explained by an effect of CCK to interfere with
the orexigenic actions of NPY, or by independent effects of
NPY and CCK on neuronal circuits that control food intake.
To investigate whether the response of key hindbrain nuclei
to CCK is also attenuated by icv NPY pretreatment, we
measured cFLI in key brain areas as an index of regional
neuronal activation. The key finding of this experiment was
that third-ventricular NPY injection significantly reduced the
number of cFLI-positive nuclei induced by CCK throughout
the AP and medial NTS. This finding supports the hypothesis
that CCK-induced activation of key hindbrain neurons is
attenuated by icv NPY administration.
The site of the NPY receptor population where NPY in-
hibited the response of NTS and AP neurons to CCK cannot
be ascertained from this study. It is conceivable that third-
ventricular NPY entered CSF in the 4th ventricle, from where
it was able to exert inhibitory effects directly on CCK-
sensitive hindbrain neurons containing NPY receptors. Al-
ternatively, NPY may have acted upon forebrain sites in-
volved in food intake regulation, such as the PVN. This brain
area contains NPY receptors (47), is richly supplied with
NPY-containing fibers emanating from the ARC (48, 49), and
is highly sensitive to NPY’s orexigenic effects (50). Because
PVN neurons are located adjacent to the third ventricle and
project directly to the NTS (reviewed in Ref. 40), NPY inhi-
bition of CCK-responsive neurons could have occurred in-
directly via this highly integrative hypothalamic nucleus.
The role of the PVN and other neuronal subsets, as mediators
of the inhibitory effect of NPY on brainstem responses to
CCK, warrants additional study.
In conclusion, our findings support the hypothesis that fast-
ing attenuates the satiety response to CCK via a mechanism
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involving decreased leptin signaling. These findings support a
model in which CCK’s satiety effects are modulated in pro-
portion to changes in energy balance, and that leptin signaling
plays a key role in this process. In addition, our data suggest that
the opposing effects of NPY and CCK on food intake involve
interactions with specific subsets of neurons in the brain stem
and provide a novel mechanism whereby NPY may increase
food intake. Thus, the ability of reduced leptin signaling to
attenuate the response to exogenous CCK may involve hypo-
thalamic mediators such as NPY. Because sc leptin injections are
limited in their ability to reduce body weight in humans (51),
our findings suggest a potential application for drugs targeting
the control of short-term food intake, given in combination with
those that regulate long-term energy balance, as an approach to
obesity treatment.
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